Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like Russia Allegedly Behind Merck's Cyberattack Last Year February 15, 2018 InspireMD Announces Distribution Agreement For CGuard EPS In Taiwan June 7, 2017 <b>Phosphorus</b> Announces Formation Of Scientific Advisory Board February 28, 2017
